- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Abcam PLC (ABCZY)
| Open: | 6.9400 | Day's Range: | 6.9400 - 6.9400 | Volume: | 826 |
|---|---|---|---|---|---|
| Previous Close: | 6.8000 | 52wk Range: | 6.3500 - 7.2400 | 1-Yr Rtn: | - |
Key Statistics for ABCZY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,383.32 |
| Shares Outstanding (M) | 199.33 |
| 30 Day Average Volume | 484 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.85% |
| Cash Dividend (USD) | 0.0237 |
| Last Dividend | 03/20/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABCZY
Company Profile & Key Executives for ABCZY
Abcam PLC produces and distributes research-grade antibodies via an online catalog. The Company's customers include universities, research institutes, and pharmaceutical and biotechnology companies in countries around the world.
| Jonathan MilnerCEO/Co-Founder | Jeff IliffeCFO/Secretary |
| Jim WarwickChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABCZY News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page